Embrace operational excellence

From discovery to delivery, we work to improve the efficiency and effectiveness of our operations. These activities support our profitable growth and free up resources to invest in innovation for patients. In everything we do, patient safety and product quality remain paramount.

2021 highlights


Launch brands and growth-driver products
contribution to Innovative Medicines Division net sales

71 bn

Treatments supplied
through Novartis manufacturing sites


Regulatory inspections
of our facilities deemed acceptable without major findings

12 064

Suppliers risk-assessed
through our third-party risk management framework

In this section

Strengthening product launches We aim to consistently deliver successful launches to support our financial performance and enable broad and rapid access to our medicines.

Transforming manufacturing We are transforming our manufacturing operations to support our strategy while reducing the environmental footprint of our facilities.

Ensuring patient health and safety Patient health and safety is fundamental to our purpose. Our activities are focused on three areas: product quality, pharmacovigilance and combating falsified medicines.

Managing our supply chain responsibly We promote ethical behavior and foster environmental sustainability across our supply chain.

Delivering effective business services Our business services and digital teams improve productivity while enabling our people to execute on our strategy and deliver on our purpose.